Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07849894 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UCB0159 in Participants With Mild to Moderate Psoriasis, Single Dose Pharmacokinetics and Safety in Healthy Participants.

Name: A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UCB0159 in Participants With Mild to Moderate Psoriasis, Single Dose Pharmacokinetics and Safety in Healthy Participants. — clinical trial record (NCT07849894)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhasePhase 1

SponsorUCB Biopharma SRL

Started2017-06-23

View on ClinicalTrials.gov ↗

UCB Biopharma SRL

68 trials monitored

See 4 trials at risk

Psoriasis

418 trials monitored

See 17 trials at risk

The purpose of the study is to evaluate the safety and pharmacokinetics of UCB0159 administered in participants with mild to moderate plaque psoriasis and evaluate single dose pharmacokinetics and safety of UCB0159 in healthy participants.

Trial Details

NCT Number	NCT07849894
Lead Sponsor	UCB Biopharma SRL
Conditions	Mild to Moderate Psoriasis, Healthy Volunteers
Enrollment	54 participants
Start Date	2017-06-23
Primary Completion	2018-12-08 (estimated)
Study Completion	2018-12-08 (estimated)
Updated on ClinicalTrials.gov	2026-09-30